WallStreetZenWallStreetZen

NASDAQ: LYEL
Lyell Immunopharma Inc Stock Ownership - Who owns Lyell Immunopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lyell Immunopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Otis W. BrawleyDirector2025-03-3135,640$0.56
$19.96kBuy
Sumant RamachandraDirector2025-03-21200,000$0.58
$115.20kBuy
Charles W. NewtonChief Financial Officer2025-03-17200,000$0.56
$111.60kBuy
Richard KlausnerDirector2025-03-14158,000$0.60
$94.96kBuy
Lynn SeelyPresident and CEO2025-03-14175,000$0.61
$106.23kBuy

1 of 1

LYEL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LYEL insiders and whales buy or sell their stock.

LYEL Shareholders

What type of owners hold Lyell Immunopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert Nelsen369.88%54,619,074$531.99MInsider
Arch Venture Partners IX LLC246.58%36,412,716$354.66MInsider
Glaxosmithkline PLC204.87%30,253,189$294.67MInsider
Mwg Management Ltd136.54%20,162,332$196.38MInstitution
Foresite Capital Management IV LLC108.40%16,007,999$155.92MInstitution
Orland Properties Ltd102.22%15,093,969$147.02MInstitution
Blackrock Inc86.15%12,721,571$123.91MInstitution
Decheng Capital LLC80.65%11,909,341$116.00MInstitution
Vanguard Group Inc65.94%9,737,729$94.85MInstitution
Richard Klausner62.72%9,262,406$90.22MInsider

1 of 3

LYEL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LYEL52.53%47.47%Net BuyingNet Buying
MOLN9.72%0.00%
FATE62.01%37.99%Net Buying
CGEN16.85%0.00%
KYTX53.51%46.49%
View Top Biotech Stocks

Lyell Immunopharma Stock Ownership FAQ

Who owns Lyell Immunopharma?

Lyell Immunopharma (NASDAQ: LYEL) is owned by 1,031.75% institutional shareholders, 932.25% Lyell Immunopharma insiders, and 0.00% retail investors. Robert Nelsen is the largest individual Lyell Immunopharma shareholder, owning 54.62M shares representing 369.88% of the company. Robert Nelsen's Lyell Immunopharma shares are currently valued at $531.99M.

If you're new to stock investing, here's how to buy Lyell Immunopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.